A single-center study on total mastectomy versus skin-sparing mastectomy in case of pure ductal carcinoma in situ of the breast
- PMID: 30683448
- DOI: 10.1016/j.ejso.2019.01.014
A single-center study on total mastectomy versus skin-sparing mastectomy in case of pure ductal carcinoma in situ of the breast
Abstract
Introduction: Ductal carcinoma in situ (DCIS) accounts for 15% of all breast cancers and generally, the prognosis is good if treated optimally. The standard treatment includes breast conservative surgery along with adjuvant radiotherapy. Skin-sparing mastectomy (SSM) preserves the breast skin envelope but its oncological safety poses a few concerns. Moreover, no DCIS-specific studies have compared the local recurrence (LR) rate following total mastectomy (TM) or SSM. We evaluated the LR rate in DCIS patients who underwent either TM or SSM.
Methods: This is a retrospective study on women who underwent mastectomy with or without immediate breast reconstruction or secondary reconstruction for pure DCIS of the breast. All patients treated at Institut Bergonié by mastectomy for DCIS from January 1990 to December 2010 were included. LR and overall survival (OS) rates were estimated.
Results: The study population included 399 patients who were categorized into two groups, 207 in the TM group and 192 in the SSM group. At 10 years of follow-up, the LR rate was 0.97% in the TM group and 1.04% in the SSM group (p = NS). The OS of the entire population was 94.7% [95% CI; 91.6-96.7], 92.8% [95% CI, 87.9-95.8] for the TM group and 96.8% [95% CI, 91.6-98.8] for the SSM group.
Conclusions: In our study, the LR rate following mastectomy is low, regardless of the surgical technique used, with an excellent OS at 10 years.
Keywords: Ductal carcinoma in situ; Relapses; Skin sparing mastectomy; Total mastectomy.
Copyright © 2019. Published by Elsevier Ltd.
Similar articles
-
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study.Eur J Surg Oncol. 2024 Feb;50(2):107938. doi: 10.1016/j.ejso.2023.107938. Epub 2023 Dec 28. Eur J Surg Oncol. 2024. PMID: 38199004
-
Oncological Safety of Skin-Sparing Mastectomy and Immediate Breast Reconstruction in Extensive Ductal Carcinoma In Situ.J Surg Res. 2022 Nov;279:25-32. doi: 10.1016/j.jss.2022.05.007. Epub 2022 Jun 16. J Surg Res. 2022. PMID: 35717793
-
Skin-sparing mastectomy and immediate breast reconstruction: patient satisfaction and clinical outcome.Int J Clin Oncol. 2006 Feb;11(1):51-4. doi: 10.1007/s10147-005-0538-1. Int J Clin Oncol. 2006. PMID: 16508729
-
Oncological and aesthetic considerations of skin-sparing mastectomy.Breast Cancer Res Treat. 2008 Oct;111(3):391-403. doi: 10.1007/s10549-007-9801-7. Epub 2007 Oct 28. Breast Cancer Res Treat. 2008. PMID: 17965954 Review.
-
Skin-sparing mastectomy.Br J Surg. 2006 Mar;93(3):276-81. doi: 10.1002/bjs.5257. Br J Surg. 2006. PMID: 16400706 Review.
Cited by
-
Oncologic outcomes after immediate breast reconstruction following mastectomy: comparison of implant and flap using propensity score matching.BMC Cancer. 2020 Jan 30;20(1):78. doi: 10.1186/s12885-020-6568-2. BMC Cancer. 2020. PMID: 32000718 Free PMC article.
-
Skin-sparing mastectomy for the treatment of breast cancer.Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD010993. doi: 10.1002/14651858.CD010993.pub2. Cochrane Database Syst Rev. 2023. PMID: 36972145 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous